Clinical Trial Detail

NCT ID NCT01857271
Title Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Albert Einstein College of Medicine of Yeshiva University
Indications

lung non-small cell carcinoma

Therapies

Erlotinib

Age Groups: adult senior

No variant requirements are available.